LifeTech Scientific Corporation (1302.HK)
HKD 1.48
(-1.33%)
HKD 1.48
(-1.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 253.46 Million CNY | -56.41% |
| 2022 | 445.78 Million CNY | 12.92% |
| 2021 | 397.58 Million CNY | 230.25% |
| 2020 | 133.29 Million CNY | -41.39% |
| 2019 | 246.22 Million CNY | 11.42% |
| 2018 | 200.02 Million CNY | -3.37% |
| 2017 | 211.45 Million CNY | 75.9% |
| 2016 | 120.09 Million CNY | 45.86% |
| 2015 | 82.33 Million CNY | 39.1% |
| 2014 | 59.19 Million CNY | 21.97% |
| 2013 | 48.53 Million CNY | -13.77% |
| 2012 | 56.28 Million CNY | 153.74% |
| 2011 | 22.18 Million CNY | -43.44% |
| 2010 | 39.21 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 104.23 Million CNY | 0.0% |
| 2024 Q1 | 104.23 Million CNY | 71.27% |
| 2023 Q3 | 60.86 Million CNY | -54.96% |
| 2023 Q4 | 60.86 Million CNY | 0.0% |
| 2023 Q2 | 135.13 Million CNY | 0.0% |
| 2023 Q1 | 135.13 Million CNY | 49.85% |
| 2023 FY | - CNY | -56.41% |
| 2022 FY | - CNY | 12.92% |
| 2022 Q1 | 120.75 Million CNY | 37.91% |
| 2022 Q4 | 90.18 Million CNY | 0.0% |
| 2022 Q3 | 90.18 Million CNY | -25.32% |
| 2022 Q2 | 120.75 Million CNY | 0.0% |
| 2021 Q2 | 119.61 Million CNY | 0.0% |
| 2021 Q3 | 87.56 Million CNY | -26.8% |
| 2021 Q4 | 87.56 Million CNY | 0.0% |
| 2021 FY | - CNY | 230.25% |
| 2021 Q1 | 119.61 Million CNY | 1169.53% |
| 2020 Q4 | -11.18 Million CNY | 0.0% |
| 2020 Q3 | -11.18 Million CNY | -116.66% |
| 2020 Q1 | 67.12 Million CNY | 48.54% |
| 2020 FY | - CNY | -41.39% |
| 2020 Q2 | 67.12 Million CNY | 0.0% |
| 2019 Q1 | 67.02 Million CNY | 60.42% |
| 2019 FY | - CNY | 11.42% |
| 2019 Q4 | 45.18 Million CNY | 0.0% |
| 2019 Q2 | 67.02 Million CNY | 0.0% |
| 2019 Q3 | 45.18 Million CNY | -32.58% |
| 2018 Q1 | 52.77 Million CNY | 47.96% |
| 2018 FY | - CNY | -3.37% |
| 2018 Q4 | 41.77 Million CNY | 0.0% |
| 2018 Q3 | 41.77 Million CNY | -20.84% |
| 2018 Q2 | 52.77 Million CNY | 0.0% |
| 2017 Q3 | 35.67 Million CNY | -25.9% |
| 2017 Q2 | 48.14 Million CNY | 0.0% |
| 2017 FY | - CNY | 75.9% |
| 2017 Q1 | 48.14 Million CNY | 98.16% |
| 2017 Q4 | 35.67 Million CNY | 0.0% |
| 2016 Q4 | 24.29 Million CNY | 0.0% |
| 2016 FY | - CNY | 45.86% |
| 2016 Q2 | 31.47 Million CNY | 0.0% |
| 2016 Q1 | 31.47 Million CNY | 38.69% |
| 2016 Q3 | 24.29 Million CNY | -22.82% |
| 2015 Q3 | 22.69 Million CNY | -19.3% |
| 2015 Q2 | 28.12 Million CNY | 0.0% |
| 2015 Q1 | 28.12 Million CNY | 56.93% |
| 2015 FY | - CNY | 39.1% |
| 2015 Q4 | 22.69 Million CNY | 0.0% |
| 2014 Q3 | 17.92 Million CNY | 24.11% |
| 2014 Q2 | 14.43 Million CNY | 0.0% |
| 2014 Q1 | 14.43 Million CNY | 24.25% |
| 2014 FY | - CNY | 21.97% |
| 2014 Q4 | 17.92 Million CNY | 0.0% |
| 2013 Q2 | 8.6 Million CNY | -20.59% |
| 2013 Q3 | 10.5 Million CNY | 22.05% |
| 2013 Q4 | 11.62 Million CNY | 10.63% |
| 2013 FY | - CNY | -13.77% |
| 2013 Q1 | 10.83 Million CNY | 136.38% |
| 2012 Q4 | 4.58 Million CNY | -70.5% |
| 2012 Q2 | 16.06 Million CNY | 25.8% |
| 2012 Q3 | 15.54 Million CNY | -3.24% |
| 2012 FY | - CNY | 153.74% |
| 2012 Q1 | 12.76 Million CNY | 907.73% |
| 2011 FY | - CNY | -43.44% |
| 2011 Q2 | 9.08 Million CNY | 118.49% |
| 2011 Q3 | 1.41 Million CNY | -84.43% |
| 2011 Q4 | 1.26 Million CNY | -10.46% |
| 2011 Q1 | 4.16 Million CNY | 0.0% |
| 2010 Q3 | 6.44 Million CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 104.43 Million HKD | -142.705% |